Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Navidea Biopharmaceuticals
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
AIDS Malignancy Consortium
AIDS Malignancy Consortium
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service
NIH AIDS Clinical Trials Information Service